Ignite Creation Date:
2024-05-06 @ 4:20 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04953104
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2021-06-28
Brief Title:
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Urothelial Carcinoma |
| Locally Advanced Bladder Urothelial Carcinoma |
| Locally Advanced Renal Pelvis Urothelial Carcinoma |
| Locally Advanced Ureter Urothelial Carcinoma |
| Locally Advanced Urethral Urothelial Carcinoma |
| Locally Advanced Urothelial Carcinoma |
| Metastatic Bladder Urothelial Carcinoma |
| Metastatic Renal Pelvis Urothelial Carcinoma |
| Metastatic Ureter Urothelial Carcinoma |
| Metastatic Urethral Urothelial Carcinoma |
| Metastatic Urothelial Carcinoma |
| Recurrent Bladder Urothelial Carcinoma |
| Recurrent Renal Pelvis Urothelial Carcinoma |
| Recurrent Ureter Urothelial Carcinoma |
| Recurrent Urethral Urothelial Carcinoma |
| Recurrent Urothelial Carcinoma |
| Stage III Bladder Cancer AJCC v8 |
| Stage III Renal Pelvis Cancer AJCC v8 |
| Stage III Ureter Cancer AJCC v8 |
| Stage III Urethral Cancer AJCC v8 |
| Stage IIIA Bladder Cancer AJCC v8 |
| Stage IIIB Bladder Cancer AJCC v8 |
| Stage IV Bladder Cancer AJCC v8 |
| Stage IV Renal Pelvis Cancer AJCC v8 |
| Stage IV Ureter Cancer AJCC v8 |
| Stage IV Urethral Cancer AJCC v8 |
| Stage IVA Bladder Cancer AJCC v8 |
| Stage IVB Bladder Cancer AJCC v8 |
| Unresectable Bladder Urothelial Carcinoma |
| Unresectable Renal Pelvis Urothelial Carcinoma |
| Unresectable Ureter Urothelial Carcinoma |
| Unresectable Urethral Urothelial Carcinoma |
Keywords: